Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 8,570 $ 4,801
Prepaid expenses and other current assets 3,429 6,887
Current portion of restricted cash 60 30
Total current assets 12,059 11,718
Property and equipment, net 461 572
Restricted cash, less current portion 66 60
Other assets 13,684 13,401
Total assets 26,270 25,751
Current liabilities:    
Accounts payable 2,645 15,486
Accrued expenses 2,229 12,458
Derivative liability 26,097  
Current portion of long-term debt 6,084 5,800
Current portion of royalty-linked notes 74  
Income taxes payable   200
Other current liabilities 3,737 3,042
Total current liabilities 40,866 36,986
Long-term debt, less current portion 21,653 7,625
Royalty-linked notes, less current portion 12,492  
Other liabilities 7,162 7,378
Total liabilities 82,173 51,989
Commitments and contingencies (Note 13)
Shareholders’ deficit:    
Undesignated preferred shares, $0.01 par value per share: 100,000,000 shares authorized at September 30, 2020 and December 31, 2019; no shares issued at September 30, 2020 and December 31, 2019
Ordinary shares, $0.01 par value per share: 150,000,000 shares authorized, 21,239,093 shares issued at September 30, 2020; 50,000,000 shares authorized, 14,868,973 shares issued at December 31, 2019 212 149
Additional paid-in capital 219,628 208,536
Accumulated deficit (275,743) (234,923)
Total shareholders' deficit (55,903) (26,238)
Total liabilities and shareholders’ deficit $ 26,270 $ 25,751